Valuation — not yet established
No valuation for Vedanta Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($366.1M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Vedanta Biosciences
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2023 | Later Stage VC | $118.5M | ▮ | ▮ |
| Jul 2021 | Later Stage VC | $68.4M | ▮ | ▮ |
| Sep 2019 | Early Stage VC | $8.0M | ▮ | ▮ |
| Dec 2018 | Early Stage VC | $45.4M | ▮ | ▮ |
How Vedanta Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vedanta Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Vedanta Biosciences raised?
- Vedanta Biosciences has raised $366.1M in total funding across 4 recorded rounds.
- When did Vedanta Biosciences last raise?
- Vedanta Biosciences last raised in Mar 2023 (Later Stage VC), raising $118.5M.